Relmada Therapeutics Inc (RLMD)
3.49
+0.01
(+0.29%)
USD |
NASDAQ |
May 16, 16:00
3.48
-0.01
(-0.29%)
Pre-Market: 20:00
Relmada Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
February 28, 2014 | 0.00 |
November 30, 2013 | 0.00 |
August 31, 2013 | 0.00 |
May 31, 2013 | 0.00 |
February 28, 2013 | 0.00 |
Date | Value |
---|---|
November 30, 2012 | 0.00 |
August 31, 2012 | 0.00 |
May 31, 2012 | 0.00 |
February 29, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.00 |
Lifecore Biomedical Inc | -- |
Harrow Inc | 184.15M |
Corvus Pharmaceuticals Inc | -- |
Aquestive Therapeutics Inc | 28.78M |